nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—Apraclonidine—ADRA1A—polycystic ovary syndrome	0.0308	0.296	CrCbGaD
Lofexidine—Clonidine—ADRA1D—polycystic ovary syndrome	0.0269	0.259	CrCbGaD
Lofexidine—Clonidine—ADRA1B—polycystic ovary syndrome	0.0229	0.221	CrCbGaD
Lofexidine—Clonidine—ADRA1A—polycystic ovary syndrome	0.0154	0.149	CrCbGaD
Lofexidine—Clonidine—CYP1A1—polycystic ovary syndrome	0.00788	0.0757	CrCbGaD
Lofexidine—HTR1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00171	0.00191	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0017	0.0019	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0017	0.0019	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PDE3B—polycystic ovary syndrome	0.0017	0.00189	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00167	0.00186	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00166	0.00185	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00162	0.00181	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0016	0.00179	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.0016	0.00179	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.0016	0.00178	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00159	0.00177	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00158	0.00176	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00154	0.00172	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00154	0.00172	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00154	0.00172	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00152	0.0017	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.0015	0.00168	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.0015	0.00167	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00147	0.00164	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00145	0.00162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00145	0.00162	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00145	0.00161	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00144	0.00161	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00142	0.00158	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00142	0.00158	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00141	0.00157	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.0014	0.00156	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00137	0.00153	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00136	0.00152	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00136	0.00152	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00134	0.0015	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00133	0.00149	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00133	0.00149	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00131	0.00147	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.0013	0.00146	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NMNAT3—polycystic ovary syndrome	0.00128	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00126	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00126	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00126	0.0014	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00125	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00125	0.00139	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00124	0.00139	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00124	0.00138	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00121	0.00135	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00121	0.00135	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00121	0.00135	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00118	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPCAT2—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SUOX—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00114	0.00127	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00113	0.00127	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00113	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.0011	0.00123	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00109	0.00122	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NPB—polycystic ovary syndrome	0.00109	0.00122	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ISYNA1—polycystic ovary syndrome	0.00109	0.00122	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00108	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00108	0.0012	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00108	0.0012	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00107	0.0012	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00107	0.00119	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00106	0.00118	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00105	0.00117	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00103	0.00115	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00101	0.00113	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000994	0.00111	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000993	0.00111	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000987	0.0011	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000982	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000982	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000977	0.00109	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000974	0.00109	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00097	0.00108	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000967	0.00108	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00096	0.00107	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00094	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKR1C2—polycystic ovary syndrome	0.000928	0.00104	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TEAD2—polycystic ovary syndrome	0.000928	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00092	0.00103	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000911	0.00102	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000911	0.00102	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000894	0.000997	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PLAT—polycystic ovary syndrome	0.000888	0.000991	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000887	0.00099	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000878	0.00098	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00086	0.00096	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000858	0.000957	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000857	0.000957	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000856	0.000956	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000856	0.000955	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000852	0.000951	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00085	0.000949	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000847	0.000946	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000831	0.000927	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000827	0.000923	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000822	0.000917	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000813	0.000907	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000811	0.000906	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000805	0.000898	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000796	0.000889	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000784	0.000875	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000781	0.000872	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PNPLA2—polycystic ovary syndrome	0.000778	0.000868	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000776	0.000866	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000772	0.000861	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000762	0.000851	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00076	0.000848	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000754	0.000842	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SRD5A1—polycystic ovary syndrome	0.000737	0.000823	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000732	0.000817	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000723	0.000807	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000716	0.000799	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000716	0.000799	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000714	0.000797	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—STAR—polycystic ovary syndrome	0.000703	0.000785	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00069	0.00077	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—GNAS—polycystic ovary syndrome	0.000681	0.000761	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000674	0.000752	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00067	0.000747	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000667	0.000744	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000653	0.000729	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00065	0.000726	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00065	0.000726	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000648	0.000724	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000632	0.000706	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000627	0.0007	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	0.000627	0.000699	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000616	0.000688	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00061	0.000681	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000598	0.000667	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000594	0.000663	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000591	0.00066	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000587	0.000655	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.00058	0.000647	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000575	0.000642	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000567	0.000633	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000561	0.000626	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000559	0.000624	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000549	0.000613	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000548	0.000612	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	0.000545	0.000609	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000544	0.000607	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000537	0.000599	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000533	0.000595	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000524	0.000585	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000519	0.000579	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000516	0.000576	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000513	0.000573	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00051	0.000569	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00051	0.000569	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000505	0.000564	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000498	0.000555	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000493	0.00055	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000479	0.000535	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000475	0.00053	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000472	0.000527	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000467	0.000521	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000465	0.000519	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000464	0.000518	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000461	0.000515	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	0.00046	0.000513	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000456	0.000509	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000446	0.000497	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000445	0.000497	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	0.000443	0.000495	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	0.000441	0.000493	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	0.000441	0.000492	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000432	0.000482	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000431	0.000481	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000427	0.000477	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	0.000426	0.000475	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000423	0.000472	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000422	0.000471	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000421	0.00047	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000419	0.000468	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000416	0.000464	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000412	0.00046	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000408	0.000455	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000401	0.000447	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000397	0.000443	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000397	0.000443	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000391	0.000437	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000391	0.000436	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000383	0.000427	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000383	0.000427	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000371	0.000414	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000369	0.000412	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000366	0.000408	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000365	0.000408	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000356	0.000398	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000355	0.000396	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.00035	0.00039	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	0.000338	0.000378	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000337	0.000376	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000335	0.000374	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000334	0.000373	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000332	0.000371	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000329	0.000367	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000327	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000324	0.000361	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000322	0.000359	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000317	0.000354	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	0.00031	0.000345	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000301	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000301	0.000336	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000294	0.000328	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00029	0.000324	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000288	0.000322	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000287	0.00032	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00028	0.000313	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00028	0.000313	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000279	0.000311	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	0.000276	0.000308	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000275	0.000307	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000265	0.000296	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000263	0.000294	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	0.000263	0.000294	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000263	0.000293	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000253	0.000282	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	0.00025	0.000278	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000249	0.000278	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000235	0.000263	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	0.000233	0.00026	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000231	0.000258	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.00023	0.000257	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00022	0.000246	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000216	0.000241	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000206	0.000229	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000198	0.000221	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000197	0.00022	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00019	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00019	0.000212	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	0.000189	0.000211	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	0.000186	0.000208	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000185	0.000207	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	0.000185	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000181	0.000202	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000181	0.000202	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000162	0.00018	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000156	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	0.000155	0.000173	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00015	0.000167	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00015	0.000167	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000146	0.000162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000142	0.000159	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000124	0.000139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000114	0.000128	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.77e-05	0.000109	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	8.6e-05	9.6e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	6.76e-05	7.54e-05	CbGpPWpGaD
